Action plan treats human and animal health as interconnected
The European commission has launched a plan to tackle antimicrobial resistance through concrete actions, including stricter monitoring of antibiotic use in farm animals, boosting research into epidemiology and reinforcing cooperation with institutions such as the World Health Organization.
The number of bacteria strains resistant to antibiotics in humans has remained stable in the Netherlands over the past year. However, outbreaks of resistant strains of bacteria in healthcare institutions are still reported occasionally. This is expected to happen more often in the future, leaving vulnerable people at an increased risk of getting ill. This is shown in the annual NethMap/MARAN report, which contains information about antibiotic use and antimicrobial resistance in the Netherlands for both humans and animals.
The Dutch Ministry of Ministry of Health, Welfare and Sport and NWO Domain TTW have jointly commissioned an ambitious research programme on the development of new antibiotics and alternatives to antibiotics. As a result, we present here the Call for Proposals focusing on ´Novel Antibacterial Compounds and Therapies Antagonizing Resistance’ (NACTAR). The main goal of the programme is to facilitate research and development of new antimicrobial molecules and alternatives to antibiotics, which should become available for the healthcare system for a fair and affordable price.
Only proposals that have taken part in the pre-proposal phase, will be accepted in the full proposal phase. Deadline pre-proposal phase is 27 June, 14:00 hrs.
On 18 April 2017, the Netherlands Antibiotic Development Platform (NADP) was launched in Utrecht with the project partner, and representatives from science, industry, and government. The aim of the launch event was to show how NADP can help facilitate the next step from academic discovery to accelerate R&D to develop new antibiotics and alternatives to antibiotics.
Within the Netherlands Antibiotic Development Platform (NADP), knowledge institutions and the business community will work together to develop new antibiotics and alternatives. The core mission of NADP is to bring companies and research groups together to accelerate research into the development of new antibiotics and alternatives to antibiotics. NADP will thereby focus on organisations that work on the treatment and prevention of bacterial infections in humans and animals. A new public-private research programme by the Netherlands Organisation for Scientific Research (NWO) domain Applied and Technical Sciences (NWO TTW) will support these developments.
The NWO-domain Applied and Engineering Sciences (TTW) will be launching a new research programme to support support the acceleration of the development of new antibiotics and alternatives.